EP3478168A1 - Dispositif de détection d'au moins un trouble du rythme cardiaque - Google Patents
Dispositif de détection d'au moins un trouble du rythme cardiaqueInfo
- Publication number
- EP3478168A1 EP3478168A1 EP17740452.2A EP17740452A EP3478168A1 EP 3478168 A1 EP3478168 A1 EP 3478168A1 EP 17740452 A EP17740452 A EP 17740452A EP 3478168 A1 EP3478168 A1 EP 3478168A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- time series
- interval
- signal
- intervals
- processor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000033764 rhythmic process Effects 0.000 title claims abstract description 105
- 230000000747 cardiac effect Effects 0.000 title claims abstract description 50
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 63
- 239000000470 constituent Substances 0.000 claims description 27
- 238000001514 detection method Methods 0.000 claims description 27
- 206010003658 Atrial Fibrillation Diseases 0.000 claims description 25
- 206010003119 arrhythmia Diseases 0.000 claims description 9
- 238000012544 monitoring process Methods 0.000 claims description 9
- 230000001133 acceleration Effects 0.000 claims description 6
- 210000000707 wrist Anatomy 0.000 claims description 2
- 238000000034 method Methods 0.000 description 35
- 238000012512 characterization method Methods 0.000 description 21
- 230000008859 change Effects 0.000 description 20
- 230000000875 corresponding effect Effects 0.000 description 17
- 238000004364 calculation method Methods 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 15
- 238000010586 diagram Methods 0.000 description 11
- 239000010750 BS 2869 Class C2 Substances 0.000 description 10
- 238000004422 calculation algorithm Methods 0.000 description 9
- 238000004891 communication Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000010749 BS 2869 Class C1 Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000000718 qrs complex Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 4
- 230000002861 ventricular Effects 0.000 description 4
- 230000001594 aberrant effect Effects 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 238000009795 derivation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000013186 photoplethysmography Methods 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 238000013473 artificial intelligence Methods 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000007477 logistic regression Methods 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000028161 membrane depolarization Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000013139 quantization Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000002102 Atrial Premature Complexes Diseases 0.000 description 1
- 206010003662 Atrial flutter Diseases 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 206010015856 Extrasystoles Diseases 0.000 description 1
- 208000004301 Sinus Arrhythmia Diseases 0.000 description 1
- 208000007888 Sinus Tachycardia Diseases 0.000 description 1
- 208000003734 Supraventricular Tachycardia Diseases 0.000 description 1
- 206010049447 Tachyarrhythmia Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 208000009729 Ventricular Premature Complexes Diseases 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 238000002790 cross-validation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009177 electrical depolarization Effects 0.000 description 1
- 238000002001 electrophysiology Methods 0.000 description 1
- 230000007831 electrophysiology Effects 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000000491 multivariate analysis Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 210000004205 output neuron Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000013577 regulation of ventricular cardiomyocyte membrane repolarization Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 208000003663 ventricular fibrillation Diseases 0.000 description 1
- 206010047302 ventricular tachycardia Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Definitions
- the present invention relates to a method and a device for detecting a cardiac rhythm disorder of a human or animal subject from a physiological signal containing information on the subject's cardiac rhythm.
- the present invention relates more particularly but not exclusively to the realization of a portable device for ensuring a continuous monitoring of the cardiac activity of a subject.
- Atrial fibrillation is the most common cardiac arrhythmia, responsible for a large number of hospital admissions for rhythmic problems. It is estimated that one in six people over the age of 40 will experience this arrhythmia, which currently affects several million subjects. Its prevalence in the population increases with age, reaching 1.5% over 50 years and more than 20% over 80 years. Atrial fibrillation is also responsible for 10 to 15% of all stroke and 25% of stroke after 80 years. In nearly a third of cases, atrial fibrillation is asymptomatic, behaving like a "silent killer". Due to the aging of the population, screening for atrial fibrillation is a major public health issue.
- Holter-ECG On subjects at risk, a statement of the electrocardiogram or ECG is generally practiced using a recorder event called "Holter”, or a version portable of this one, called “Holter-ECG”.
- a Holter-ECG recording typically lasts 24 hours. It has the advantage of allowing the monitoring of a patient outside the hospital environment but can not be used daily by the population.
- the heart is a muscle that contracts in a relatively regular rhythm. Each normal beat is initiated by an electrical signal generated by the cardiac electrogenic tissue and conveyed by the conduction system of the heart.
- the ECG signal consists of a succession of electrical depolarizations resulting in the appearance of waves P, Q, R, S, T, U whose appearance is shown in Figure 3.
- the P wave which corresponds at depolarization of auricles, presents a small amplitude.
- the PQ interval reflects the atrioventricular conduction time.
- the QRS complex reflects the ventricular contraction, and the T wave the ventricular repolarization.
- peak R is considered as a marker of ventricular systole, ie, heartbeat.
- the R wave is the thinnest and largest peak of the ECG signal, and is generally used to mark the moment of heartbeat with very good accuracy.
- Atrial fibrillation observed on an electrocardiogram is characterized by the replacement of P waves by rapid oscillations (called fibration waves) of varying size, shape, and frequency of occurrence, associated with an often irregular fast ventricular rhythm when atrio conduction occurs. - ventricular is intact.
- a time series of RR intervals thus consists of a plurality of successive RR intervals (... RRi 1, RRi, RRi + 1 ...) as illustrated in FIG. 3, each interval RR corresponding to the time interval separating two successive waves R of the ECG signal.
- the article "Automatic Detection of Atrial Fibrillation Using RR Interval Signal” proposes to use the mathematical operators VAI and VLI, SD1 and SD2 to distinguish time series in sinus rhythm from time series with atrial fibrillation.
- a scatter plot, said Lorenz or Poincaré graph, whose abscissa is the RR interval (RRi) and the ordinate the following RR interval (RRi + 1) of the time series, allows to represent successive RR intervals as scatterplots in which we try to distinguish those related to subjects in sinus rhythm and those attached to subjects with atrial fibrillation.
- the proposed classification criteria are purely graphical and include the NZCEL number of cells RdR of the graph comprising at least one point, the number NZCOL of columns of cells RdR having at least one point, the number NZROW of rows of cells RdR having at least one point, the NPEAK number of cells having a number of points greater than a threshold, the XDIST trajectory distance of the cloud of points along the RR axis, the maximum difference between two RR intervals, the distance YDIST trajectory of the point cloud along the dRR axis, ie the maximum difference between two dRR variations, the maximum distance DGMAX with respect to a global center of the point cloud, the maximum distance DPMAX with respect to a determined positive center from all positive value dRRs, and the maximum distance DNMAX from a negative center determined from all negative value dRRs.
- a portable device for detecting a cardiac rhythm disorder that is easy to use and is not very restrictive. can detect a rhythm disorder with good accuracy while providing the opportunity to then allow further monitoring of the subject on which the rhythm disorder has been detected, in a manner that is exploitable by the medical profession.
- Embodiments of the present invention provide a device for detecting at least one cardiac rhythm disorder of a subject, comprising a photoplethysmographic signal acquisition channel, at least one signal acquisition channel. electrocardiographic, and a processor configured to detect the cardiac rhythm disorder in the photoplethysmographic signal and in the electrocardiographic signal.
- the device is configured to, in a first mode of operation, monitor only the photoplethysmographic signal for detecting cardiac rhythm disorder, and after detecting the cardiac rhythm disorder in the photoplethysmographic signal, switch to a second mode of operation including monitoring the electrocardiographic signal for cardiac arrhythmia.
- the device is configured to, in the second mode of operation, monitor both the photoplethysmographic signal and the electrocardiographic signal.
- the device comprises a housing or fixing means receiving an acquisition electrode of the electrocardiographic signal that the subject must touch with a part of his body so that the electrocardiographic signal is captured by the acquisition channel of the electrocardiographic signal.
- the device comprises a multiplexing circuit comprising a first input receiving the photoplethysmographic signal, a second input receiving the electrocardiographic signal, and an output connected to the processor, the device being configured for, in an operating mode, selecting alternately each of the two inputs of the multiplexing circuit with a high switching frequency in front of the subject's heart rate.
- the device comprises fixing means around the wrist.
- the processor is configured to generate from the photoplethysmographic or electrocardiographic signal time series of RR intervals, and to determine whether the time series of RR intervals belong to a first class of time series of RR intervals. associated with subjects in sinus rhythm or at least a second class of RR interval time series associated with subjects having the cardiac rhythm disorder to be detected.
- the processor is configured, after detecting a cardiac rhythm disorder in the photoplethysmographic or electrocardiographic signal, to memorize the time series as well as the signal that led to the detection of the cardiac rhythm disorder.
- the processor is configured to, from a time series of RR intervals, calculate the value of at least one descriptive variable characterizing the time series of RR intervals in relation to the cardiac rhythm disorder. to detect, and use the value of the descriptive variable as discriminant information to classify the time series of RR intervals in the first or second class of time series.
- the processor is configured to calculate the value of the descriptive variable from a derived series whose constituent element is an order 1 or greater derivative of the RR interval of the time series. .
- the processor is configured to calculate the value of the descriptive variable from a derived series whose constituent element is chosen from the group comprising the rate of variation of the RR interval, ie the time derivative. of the RR interval, reflecting the acceleration of the heart rate, the absolute value of the rate of change of the RR interval, the rate of change of the rate of change of the RR interval, the discrete temporal derivative of the rate of variation of the RR interval, again the second derivative of the RR interval, reflecting the jolts of the heart rate, the absolute value of the rate of change of the rate of change of the RR interval, the rate of change of the absolute value of the rate of change of the RR interval, or the absolute value of the rate of change of the absolute value of the rate of change of the RR interval.
- the processor is configured to calculate the value of the descriptive variable from a time series whose constituent element is selected from the group comprising the RR interval, the variation of the RR interval, and the absolute value of the variation of the RR interval.
- the device comprises a classifier tool configured to determine whether the time series of RR intervals belongs to the first or second classes of time series.
- the device is configured to produce the time series according to a sliding time window, so that two successive time series can comprise common RR intervals.
- the device is configured to detect atrial fibrillation.
- the value of the descriptive variable is calculated by means of a mathematical operator selected from the group consisting of: the mean value, the median, the standard deviation, the variance, the asymmetry coefficient or Skewness, flattening coefficient or Kurtosis, ULF ultra low frequency power, VLF very low frequency power, LF low frequency power, RF high frequency power, LF / HF ratio, total power, power Normalized LF, the normalized RF power, SD1 or dispersion of the points along the small axis of the ellipse of the Poincaré diagram, SD2 or dispersion of the points along the long axis of the ellipse of the Poincaré diagram, the ratio SD1 / SD2, VAI or the vector angle index, VLI or the vector length index, RMSSD or squared mean of the successive differences of the constituent elements of the series, SDSDD or standard deviation of the absolute value of the ord differentiation re 2 of the constituent elements of the series, the recurrence rate of the recurr
- FIG. 1 represents in block form an embodiment of a device for detecting a cardiac rhythm disorder according to the invention
- FIG. 2 represents in block form another embodiment of a device for detecting a disturbance of the cardiac rhythm according to the invention
- FIG. 3 shows an electrocardiographic signal that can be used in one embodiment of the device of FIG. 1 or that of FIG. 2
- FIG. 4 shows a photoplethysmographic signal that can be used in one embodiment of the device of FIG. 1 or that of FIG. 2
- FIG. 5 is a flowchart showing an embodiment of a method for detecting a cardiac rhythm disorder implemented by the device of FIG. 1 or that of FIG. 2,
- FIG. 6 is a flowchart describing a first embodiment of a time series characterization step appearing in the method of FIG. 5,
- FIGS. 7, 8 and 9 illustrate results of studies concerning the characterization of time series
- FIG. 10 is a flowchart describing a second embodiment of the time series characterization step in the method of FIG. 5,
- FIG. 11 is a flowchart describing an embodiment of a time series classification step in the method of FIG. 5,
- FIG. 12 is a flowchart describing a learning step of a classifier tool used for the classification of time series
- FIG. 13 represents in block form an embodiment of a portable device for detecting a cardiac rhythm disorder according to the invention
- FIGS. 14A and 14B are respectively views from above and from below of the device of FIG. 13,
- FIG. 15 is a flowchart describing functionalities of an embodiment of the device of FIG. 13,
- FIG. 16 is a flowchart describing an embodiment of a method for detecting a cardiac rhythm disorder implemented by the device of FIG. 13,
- FIG. 17 is a flowchart describing another embodiment of a method for detecting a cardiac rhythm disorder implemented by the device of FIG. 13,
- FIG. 18 is a flowchart describing an embodiment of an RR interval generation step included in the method of FIG. 16 or that of FIG. 17,
- FIG. 19 is a flowchart describing an embodiment of a time series production step included in the method of FIG. 16 or that of FIG. 17,
- FIG. 20 is a flowchart describing an embodiment of a decision step included in the method of FIG. 16 or that of FIG. 17, and
- FIG. 21 is a flowchart describing other functionalities of an embodiment of the device of FIG. 13.
- FIG. 1 represents an embodiment of a device DV1 according to the invention.
- the device comprises a processor P1, an acquisition channel CH of a physiological signal S, a program memory M11, a data memory M12, and a wireless communication interface CI1.
- the acquisition channel CH is connected to an AT terminal coupled to the body of a subject that can be of any known type, in particular a cardiac probe, skin electrodes or a photoplethysmography module comprising transmitting and receiving diodes.
- the acquisition channel CH supplies the signal S in digitized form to the processor P1.
- the processor analyzes this signal to detect a disturbance of the heart rhythm, by means of program-algorithms PG1, PG2, PG3, PG4 provided in the memory Mi l.
- a clock circuit CCT may be provided to provide a clock signal CK usable as a reference time base for the measurement of RR intervals.
- the DV1 device may be of implantable type, for example subcutaneous, portable type, or fixed type that the subject uses temporarily during a phase of observation of his heart rate.
- Various other members that can be provided in the device DV1 are not shown, such as a power supply, voltage regulators, a display, physiological data or posture sensors, for example a temperature sensor, an accelerometer, a magnetometer ...
- FIG. 2 represents another embodiment of a device DV2 according to the invention.
- the device comprises a processor P2, a program memory M21, an HD data storage means, for example a hard disk, a wireless communication interface CI2 and a circuit CCT providing a clock signal CK.
- the program memory M21 comprises the aforementioned program-algorithms PG1, PG2, PG3, PG4 for the analysis of the physiological signal S and the detection of a disturbance of the cardiac rhythm.
- the signal S may be prerecorded in the HD data storage means, or received from the DV1 device via the communication interface CI2 for analysis in real time or after being recorded in the HD storage means.
- the device DV2 can be a personal computer or the computer of a doctor, a workstation in a medical laboratory, a medical server, and generally any device equipped with calculation means for implementing the PG1 programs to PG4.
- FIGS. 3 and 4 show two examples of physiological signals S that can be analyzed by the device DV1 or DV2.
- the signal shown in Fig. 3 is an ECG signal
- the signal shown in Fig. 4 is a photoplethysmographic signal, or PPG signal.
- the ECG signal shows the QRS complex corresponding to the depolarization of the ventricles, from which the R peak can be extracted for the measurement of RR intervals (RRi-1, RRi, RRi + 1 ).
- the PPG signal has a roughly sinusoidal appearance and has peaks denoted "R" by analogy with the electrocardiographic signal, the occurrence of which is representative of the subject's cardiac activity.
- the moment of occurrence of a peak "R" of the signal PPG is correlated, with a slight phase shift, at the time of occurrence of the peak R of the ECG signal, because the signal PPG accounts for the pulsatile nature Pulse resulting from cardiac contractile mechanical activity, rheological properties of the blood and mechanical properties of the vessels.
- the pseudo-period defined by the duration of the peak-to-peak interval of the PPG signal is correlated with the duration of the RR interval.
- the detection of the "R" peaks of the photoplethysmographic signal and the measurement of the time intervals between these peaks thus makes it possible to produce time intervals which will be considered in the following as RR intervals.
- the P waves and the fibrillation waves of the ECG signal are electrical events without macroscopic mechanical counterpart, and are not observable in the PPG signal.
- FIG. 5 shows steps of the method for detecting a cardiac rhythm disorder implemented by the device DV1, DV2 by means of the programs PG1 to PG4.
- the method comprises:
- the measurement of the RR intervals by the program PG1 may include a filtering for identifying aberrant RR intervals due for example to false detections and / or non-detections of RR intervals.
- the program PG2 "cuts" the continuous stream of intervals RR in time series Sj of a minimum duration Te, each comprising a number of successive intervals RR which is a function of the heart rate of the subject.
- the program PG3 analyzes the intervals RR constituting the time series Sj to extract a discriminant information necessary for their classification.
- step S09 the program PG4 uses the discriminant information to classify the time series Sj into a first class C 1 of time series from subjects in sinus rhythm or in a second class C2 of time series from subjects presenting the disorder of the rhythm to be detected, for example atrial fibrillation.
- the classification step S09 is followed by an action performed by the device DV1.
- This action can for example comprise storing in the data memory M 12 the raw signal S and / or the time series Sj in which the disturbance of the rhythm has been detected, and / or transfer these data via the communication interface. CH.
- the device DV1 can for example establish a communication with the device DV2 and transfer to it the signal S, the time series Sj and their classification.
- the device DV2 is then able to carry out, in deferred time, a verification of the classification provided by the device DV1, or even to submit the signal S to other types of analyzes aimed at confirming the validity of the classification chosen. by the device DVl.
- the action following the classification of one or more time series in class C2 may also include a decision step preceding an action proper, aimed at validating the classification chosen by the program PG4.
- FIG. 6 shows a first embodiment S07 (1) of the characterization step S07 implemented using the program PG3.
- Step S07 (1) comprises a preliminary step S070 of choice of a group of descriptive variables Val, Va2 ... Vak, corresponding here to the choice of a group of mathematical operators intended to be applied to time series d. RR intervals.
- Step S070 is preferably performed prior to commissioning the DV1, DV2 device and writing the PG3 program, through studies and trials to determine the best combination of descriptive variables in relation to the disorder. the rhythm to detect.
- the DV1, DV2 device is configured to detect several types of rhythm disorders and uses different groups of descriptive variables, each dedicated to the detection of a particular disorder. pathology.
- the step S070 may include a step of selecting, in the program memory Mi1, M12, the appropriate group of descriptive variables, or a step of selecting a branch of the program PG3 using the group of descriptive variables. dedicated to detecting the target rhythm disorder.
- Step S07 then comprises a loop for calculating the values of each descriptive variable, which is initiated after reception, during a step S071, of a new time series Sj provided by the program PG2.
- the calculation loop comprises a step S072 for calculating the value Valj of the descriptive variable Val, a step S073 for calculating the value Va2j of the descriptive variable Va2, and so on until a step S07k for calculating the value Vakj of the descriptive variable Vak, the value of each variable being calculated from the RR intervals of the series Sj.
- the program PG3 then supplies the program PG4 with the values Valj, Va2j ... Vakj of the descriptive variables.
- RR intervals provided by the Massachusetts Institute of Technology (MIT) Physionet site (http://www.physionet.org/), which is available to the public.
- ECG signal banks and RR interval time series including "Sinus Rhythm RR Interval Database”, “MIT-BIH Normal Sinus Rhythm Database”, “MIT-BIH Atrial Fibrillation Database”, “AF Termination Challenge Database” , and "MIT-BIH Arrythmia Database”. From these databanks, a time series library of RR intervals has been constituted, including:
- the step S07 of time series characterization includes derived series calculation steps whose constituent elements are discrete derivatives, denoted by N RR / dt N , RR intervals of the initial time series, N being an integer at least equal to 1. It has indeed been demonstrated that such derived series contain discriminant information that can be added to that which can be extracted from the initial time series, or even replace it, with a view to their classification.
- the table of FIG. 7 illustrates, with shades of gray, a degree of correlation between derivatives of RR intervals of increasing order N. This degree of correlation is measured on a scale of 0 to 1 using the Pearson coefficient.
- the table in Figure 7 is reproduced in Appendix 1, Table 1, with shades of gray replaced by numerical values.
- the central diagonal from the upper left corner to the lower right corner of the table shows that, trivially, the RR intervals and their derivatives have a correlation coefficient of 1 with respect to themselves.
- diagonals close to the central diagonal show that the derivatives of RR intervals of adjacent orders (for example a derivative of order 2 and a derivative of order 3) have between them a degree of correlation of less than 1, for example order of 0.8.
- the method comprises the following steps:
- a step of characterizing the derived series by means of one or more descriptive variables whose values are calculated by applying a mathematical operator to the constituent elements of the derived series, and are considered as forming discriminant information for the classification of the initial time series.
- derived descriptive variable Vb a descriptive variable obtained by applying a mathematical operator to a derived series
- primitive series a time series of RR intervals or a time series whose constituent element is the variation of the RR interval or the absolute value of this variation
- primitive descriptive variable Vc a descriptive variable obtained by applying a mathematical operator to a primitive series.
- the concept of "derived series” includes series whose constituent element is calculated from the absolute value of the elements of a lower order derived series, for example, as will be see below, the rate of change of the absolute value of the rate of change of the RR interval, or the absolute value of this rate of change.
- Nmax denotes the maximum degree of derivation used to characterize a time series, ie the number of derived series available
- NVa the number of mathematical operators that can be applied to the derived series
- the number of derived descriptive variables that can be used is equal to NVa * Nmax.
- Ultra Low Frequency Power (ULF) or ultra low frequency power [0 - 3 mHz]
- VLF Very Low Frequency Power
- phase phase analysis operators such as:
- the table in Figure 8 illustrates the result of a study to identify the best combination of primitive and derived descriptive variables using as mathematical operators the mean value and the standard deviation ( " ⁇ ").
- the table in Figure 8 is also reproduced in Appendix 1, Table 2, the shaded areas being replaced by crosses. The study was conducted under the following conditions:
- Each column of the table corresponds to a combination of variables comprising from 1 to 10 variables. Gray cells (or, in Appendix 1, those with crosses) indicate the best choice of variables.
- Column 2 the couple of variables offering the best classification accuracy is ' is the standard deviation of the constituent elements of the second derivative and the average value of the constituent elements of the first derivative.
- a classification accuracy of 99.9% was obtained without using primitive descriptive variables.
- column 5 the standard deviation of the RR intervals of the time series is part of the optimal combination of variables.
- From column 9 (ie 9 variables used) the average value of RR intervals is also part of the optimal combination of variables.
- FIG. 9 illustrates one of the results of these studies and shows a curve C1 corresponding to the variation of the accuracy of the classification, expressed as a percentage, as a function of the duration of the observation window, expressed in seconds, in using the pair of derived descriptive variables
- the curve Cl shows that the duration of the observation window can be reduced to 5 seconds, which represents only 5 heart beats with a subject whose heart rate is 60 beats per minute, while maintaining an accuracy of classification greater than 95%.
- the reduction in the duration of the observation window makes it possible to reduce the classification time of each time series and thus to increase the reactivity of the DV1, DV2 device during the onset of a rhythm disorder, as part of a real-time monitoring of the subject's cardiac activity.
- FIG. 10 shows an embodiment S07 (2) of the characterization step S07 according to this method.
- Step S07 (2) comprises a preliminary step S0700 of choosing at least one derived descriptive variable Vb.
- this choice is preferably made before the commissioning of the DV1 or DV2 device, through prior studies, and depending on the rhythm disorder to detect. This is for example the average value of the first derivative and the standard deviation of the second derivative, the discriminant performance of which has been highlighted above in relation to FIG. 8.
- at least one variable descriptive primitive Vc can also be retained.
- this choice can be made dynamically by the device DV1, DV2 as a function of the rhythm disorder to be detected, by selecting a group of variables from among several predetermined groups or PG3 program branches configured to use these variables.
- the program PG3 After receiving a time series Sj during a step S0701, the program PG3 performs all or some of the following steps:
- step S0702 calculation of a series Sjo whose constituent element is the variation Vi of the RR interval of the series Sj,
- step S0703 calculation of a series Sji whose constituent element is the absolute value
- step S0704 calculation of a derived series Sj 2 whose constituent element is the rate of variation Ai of the RR interval (acceleration of the cardiac rhythm),
- step S0705 calculation of a derived series Sj 3 whose constituent element is the absolute value
- step S0706 calculation of a derived series Sj 4 whose constituent element is the rate of variation ACi of the variation rate Ai of the RR interval (jerk of the cardiac rhythm),
- step S0707 calculating a series derived Sj 5 whose constituent element is the absolute value
- step S0708 calculation of a derived series Sj 6 whose constituent element is the rate of change Gi of the absolute value
- step S0709 calculation of a derived series Sj 7 whose constituent element is the absolute value
- step S0720 determining the value Vclj of at least one primitive descriptive variable Vcl calculated from the series Sj,
- step S0730 determination of the value Vc2j of at least one primitive descriptive variable Vc2 calculated from the Sjo series,
- step S0740 determination of the value Vc3j of at least one primitive descriptive variable Vc3 calculated from the series Sj 1 ,
- step S0750 determining the value Vbj of at least one derived descriptive variable Vb from a derived series Sj 2 to Sj 7 .
- Steps S0720, S0730 and S0740 are optional and are not executed if the choice made in step S0700 does not include a primitive descriptive variable.
- the method may comprise only two of these steps, only one of these steps, or none of these steps.
- the number of derived descriptive variables whose values are calculated in step S0750 depends on the choice made in step S0700.
- some of the steps S0704 to S0709 may not be executed if the derived derived descriptive variables do not require the calculation of the corresponding derivatives.
- the program PG3 then supplies the program PG4 with the value or values Vbj of one or more derived descriptive variables Vb, and optionally the value or values Vcj of one or more primitive descriptive variables Vc, and returns to the step S0701 to wait to receive a new time series Sj.
- the program PG4 is a classifier tool comprising a network of artificial neurons (RNA) vector quantization and supervised learning, called "LVQ"("Learning Vector Quantization”). It has a hidden layer called competitive layer, followed by a classification layer. The competitive layer contains hidden neurons, the classification layer contains output neurons, each of which is representative of a membership class of vectors of a learning base.
- the results provided by this classifier tool architecture are of the order of 100% in learning and 99.9% in cross validation.
- the robustness of the model has also been tested in the presence of different special cases such as the presence of ectopic beats, a sinus rhythm with a strong respiratory sinus arrhythmia, etc.
- Fig. 11 shows an embodiment of the classification step S09.
- the PG4 classifier tool Prior to being commissioned, the PG4 classifier tool is subjected to a supervised learning configuration step S0900 using two sets NI, N2 of reference time series. Once the learning is finished, the program is able to classify time series in two classes C1, C2 of time series corresponding respectively to sets NI and N2.
- the PG4 classifier tool is configured to distinguish a class C1 of time series associated with subjects in sinus rhythm and a class C2 of time series associated with subjects in atrial fibrillation.
- the classifier tool PG4 receives one or more values Vbj of derived descriptive variables Vb calculated by the program PG3 at the step S07 (2) for a time series Sj, and optionally one or more values Vcj of descriptive variables. primitives Vc.
- the classifier tool PG4 evaluates, from these variables, the membership class of the series Sj. The classifier tool PG4 provides this classification and returns to step S091 to receive new values of these variables associated with a next time series.
- Fig. 12 shows an embodiment of the step of configuring the classifier tool PG4. This can be performed using a version of the classifier tool installed on a workstation and aims to obtain a set of MC4 configuration matrices. It includes the following preparatory steps:
- a step S0901 for preparing a set NI of time series derived from subjects in sinus rhythm for example the aforementioned reference time series of one minute each originating from subjects in sinus rhythm and produced from the database of the Massachussetts Institute of Technology,
- step S0902 for characterizing the time series of the set NI.
- This step therefore comprises, for each series Sj, the computation of values Vbj of derived descriptive variables Vb, and if necessary the computation of values Vcj of primitive descriptive variables Vc,
- a step S0904 for preparing a set N2 of time series from subjects presenting the disturbance of the rhythm to be detected for example a reference time series of one minute each from subjects in atrial fibrillation and produced from the database of the Massachusetts Institute of Technology
- This step therefore comprises, for each series Sj, the computation of values Vbj of derived descriptive variables Vb, and where appropriate the computation of values Vcj of primitive descriptive variables Vc.
- the values Vbj, Vcj of the variables Vb, Vc calculated for the time series of the set NI are then supplied to the classifier tool PG4 with the status "class C1" during a step S0903.
- the values Vbj, Vcj of the variables Vb, Vc calculated for the time series of the set N2 are supplied to the classifier tool PG4 with the status "class C2" during a step S0906.
- the classifier tool learns, during a step S0907, to distinguish the classes C1 and C2. This is a supervised learning since classes are imposed on the classifier tool when providing the values of the variables in steps S0903 and S0906.
- the configuration of the classifier tool resulting from the learning phase taking the form of a set of configuration matrices MC4, is then saved during a step S0908.
- the configuration matrices MC4 are loaded in the memory Mi1, M21 of the device DV1, DV2 (FIGS. 1 and 2).
- the PG4 classifier tool can be configured to provide a classification of rhythm disorders in several classes C2 (1), C2 (2), C2 (3) ... each corresponding to a particular rhythm disorder (atrial fibrillation , atrial flutter, tachyarrhythmia, supraventricular tachycardia, sinus tachycardia, atrial or ventricular extrasystole, ventricular tachycardia, ventricular fibrillation ).
- several classifying tools each configured to distinguish two classes, namely the class C1 and one of the classes C2 (1), C2 (2), C2 (3), can be provided and intervene with one another. after the others during the classification step S09.
- a classification conflict arbitration algorithm may be provided in the case where several classifiers provide different classifications.
- the classification can be implemented with other types of classifying tools than that previously described, in particular a regression classifier tool.
- logistics or other types of supervised neural networks such as those designated "LVQ2", “LVQ3", “OLVQ3” in the literature.
- Specific learning for an individual with a risk of rhythm disorder may also be provided.
- the configuration of the classifier tool includes a first supervised learning from an existing database relating to a population, as described above, then a personalized learning in relation to the subject, under medical supervision. .
- the calculation steps just described can be carried out from the instantaneous heart rate which is calculated by means of the formula 1 / RRi (number of beats per minute). second) or the formula 60 / RRi (number of beats per minute), the interval RRi then to be expressed in seconds.
- the series of RR intervals are replaced by series of instantaneous cardiac frequencies
- the derivatives of the series of intervals RR are replaced by derivatives of series of instantaneous heart rates, which are calculated in the same way as that indicated in Annex 3 by replacing the RR interval with the instantaneous frequency.
- RR interval should be understood as also referring to the instantaneous heart rate
- RR time series should be understood as also referring to instantaneous heart rate series
- derived series is to be understood as also referring to a series derived from a series of instantaneous cardiac frequencies.
- FIG. 13 represents an embodiment of a device DV3 according to the invention, intended to be worn by a user.
- the device comprises a CH1 channel for acquiring a photoplethysmographic signal S1, a CH2 channel for acquiring an electrocardiographic signal S2 (ECG) and optionally other CHn channels.
- ECG electrocardiographic signal
- Sn for example a second acquisition channel of an electrocardiographic signal, a temperature acquisition channel, a signal acquisition channel provided by an accelerometer, and a data acquisition channel.
- a signal provided by a magnetometer for example a second acquisition channel of an electrocardiographic signal, a temperature acquisition channel, a signal acquisition channel provided by an accelerometer, and a data acquisition channel.
- the channel CH1 is coupled to at least one light emitting diode ED and at least one PD photodiode.
- the CH2 channel is coupled to two dry electrodes El, E2.
- the signals S1, S2 ... Sn provided by the different acquisition channels are applied to inputs of a multiplexer MUX whose output is connected to a processor P3 via an analog-digital converter ADC.
- a LPF pass-through filter may be provided between the output of the multiplexer and the ADC converter, in order to remove noise components that may be present in the signals S1 and S2 or in one of these signals.
- the device DV3 also comprises a program memory M31, an M32 data memory, a wireless communication interface CI3, a display DS and a clock circuit CCT providing a clock signal CK forming a time base for the measurement of time. RR intervals.
- the multiplexer MUX receives a selection signal SEL supplied by the processor P3 and transfers thereto the corresponding signal S1, S2,... Sn selected on one of its inputs.
- Other peripheral means of the processor P3, schematized by a PD block may include a battery or any other power source, a power management circuit, regulators providing different bias voltages, a USB port, a piezoelectric pager. (buzzer), a buzzer, an inertial microcentral, etc.
- FIGS. 14A and 14B show the device DV3 respectively by a view from above and a view from below.
- the device is mounted in a protective case 10 equipped with a bracelet 11.
- the top of the housing 10 receives the DS display.
- the underside of the housing 10 receives the electrode El, an auxiliary electrode 12 (reference potential electrode), and a micromodule 13 of photoplethysmography.
- the photoplethysmography module 13 comprises, for example, three electroluminescent electrodes ED and a photodiode PD.
- the electrode E2 is arranged here on an outer face of the bracelet 11, FIG. 14A, but could also be arranged on one face of the case 10.
- the electrode E For the acquisition of the signal ECG S2, the electrode E being in permanent contact with the skin, the user must touch the electrode E2 with a finger of the hand opposite to that which receives the device DV1, or with any part from this hand, for example the top of the hand.
- the difference in bioelectrical potential for the acquisition of the electrocardiographic signal is thus optimal since measured between two ends of the body.
- the electronic means shown in FIG. 13 can be integrated in a bracelet, the assembly then being devoid of a case. These electronic means can also be integrated in the case of a watch, or in the wristband of a watch.
- the electrodes E1, E2 are cutaneous electrodes connected to the device DV3 by wires and microconnectors.
- Electrodes E1, E2 instead of being connected to the device DV3, are connected to an electronic module configured to transfer the ECG signal S2 to the device DV3 via a wireless communication channel.
- An advantageous general characteristic of the device DV3 is that it combines the ease of acquisition of the photoplethysmographic signal S1 (no skin electrodes to be placed on the body of the user) while allowing to acquire the electrocardiographic signal S2 when this is done. is necessary here, by a simple pressure on the electrode E2, if not by means of cutaneous electrodes wired or connected to a wireless transmitter.
- Fig. 15 shows an operating configuration of the DV3 device based on this feature.
- the DV3 device has a "continuous sleep” operating mode and an “alert” operating mode.
- the processor P3 activates the channel CH1 and continuously analyzes the photoplethysmographic signal S1.
- the processor switches to "alert” mode when a rhythm disorder is detected in the photoplethysmographic signal.
- the processor then activates the channel CH2, selects the electrocardiographic signal S2 by means of the multiplexer MUX and requests the user, by any means provided for this purpose (display DS, ringing, buzzer, voice message ...) to touch the electrode E2 for a determined time, for example for one minute.
- the electrocardiographic signal is then duly analyzed and if the rhythm disorder is confirmed, the device can ask the user for an urgent measure and / or himself conduct one or more actions to protect him.
- the processor P3 alternately selects the S1 and electrocardiographic S2 photoplethysmographic signals by rapidly switching the inputs of the multiplexer MUX by means of the signal SEL, for example with a frequency of the order of 1000 Hz or more, about 1000 times the average heart rate of a person at rest.
- the multiplexer MUX supplies the ADC converter with signals S1, S2 in a form pseudo-sampled which is digitized by the ADC converter before being analyzed by the processor P3.
- Other Sn signals can also be simultaneously provided to the processor in the "alert" mode.
- a second channel for acquiring the ECG signal using another acquisition circuitry to be chosen from among various known circuits, connected to the electrodes E1, E2 or using other electrodes, can make it possible to reinforce the reliability of the acquisition and the analysis of the ECG signal by analysis of the two ECG signals and arbitration of the results obtained.
- the analysis of the signal S1 or S2 by the processor P3 is provided by various program-algorithms loaded into the memory M31, in particular:
- the program PG4 for classifying the time series for example the classifier tool previously described and its configuration matrices MC4.
- a PG5 decision program is also planned.
- the program PG5 receives the time series classifications provided by the classifier tool PG4 and decides, in view thereof, whether it can be considered that a rhythm disorder has been detected.
- a PAP application program is provided to manage the general features of the device and its modes of operation.
- Figure 16 shows steps of a method for detecting a cardiac rhythm disorder performed by the DV3 device using the aforementioned programs.
- the method comprises a step SO1 for selecting the channel CH1 and / or CH2 and steps specific to each of the signals S1 and S2, namely:
- step S02 for filtering the signal S1 by the program PG01 followed by a step S03 (1) of detecting the "R" peaks (PPG peaks) and measuring the RR intervals by the program PG11, and
- the method then comprises signal processing steps common to each of the signals S1, S2, but applied separately thereto, including:
- step S05 for forming time series Sj from the intervals RR provided by the program PG11 or PG12, executed by the program PG2; the step S07 (2) previously described (FIG. 10) for characterizing the series time Sj, executed by the program PG3, and
- Step S09 is followed by a decision step S11 executed by the program PG5, based on the classification information provided by the classifier tool PG4.
- the program PG5 confirms the detection of a disturbance of the rhythm when a determined number "D" of successive time series have been attached to the class C2.
- an isolated classification of a time series in the C2 class is not considered sufficient to consider that the subject has a disorder of the rhythm, as well as several classifications in the C2 class of time series that are not successive.
- the program PG5 may equivalently be configured to confirm detection of a rhythm disorder when "D" successive time series have not been classified in the class Cl.
- This embodiment applies in particular when the classifier tool is configured to provide a classification of rhythm disorders in several classes C2 (1), C2 (2), C2 (3) ... each corresponding to a disturbance of the rhythm. the decision then taken without investigating whether the detected disorders were attached to the same class among all available C2 classes.
- the method comprises a step S 12 of initiating a specific action, carried out by the PAP application program, aimed at protecting the subject and / or the collection of information enabling the medical profession to diagnose the event.
- Fig. 17 shows another embodiment of a method for detecting a rhythm disorder performed by the DV3 device.
- This embodiment differs from the previous one by the fact that, when the electrocardiographic signal S2 is analyzed, the step of characterization S07 (2) of the time series is replaced by a characterization step S07 (3) carried out by a program PG32 which replaces the PG3 program.
- This step S07 (3) includes, in addition to the characterization of the time series in the manner previously described, a step of characterizing the morphology of the ECG signal, which comprises for example the analysis of the shape of the P wave and the QRS complex, for example their amplitude and their duration.
- the classification step S09 is replaced by a classification step S09 (2) conducted by a second classifier tool PG42 which replaces the program PG4.
- the program PG42 has MC42 configuration matrices obtained at the end of a learning phase based both on the characterization of the time series and the characterization of the morphology of the signal S2.
- the switchover in the "alert" mode enables the device DV3 to acquire the electrocardiographic signal S2 and to conduct an accurate analysis thereof, allowing the PG5 program to provide very reliable confirmation of the presence of a rhythm disorder.
- the improvement proposed above concerning the characterization of the time series by means of the derived descriptive variables Vb already makes it possible to obtain a reliable detection based on the single observation of the photoplethysmographic signal S 1.
- the algorithm executed by the processor P3 under the control of the program PG11 or PG12 in the step S03 (1) or S03 (2) is preferably designed to detect and eliminate the aberrant RR intervals and thus to further improve the reliability of the method detecting a rhythm disorder.
- FIG. 18 shows an embodiment of this algorithm, which can also be used to implement the step S03 of FIG. 5.
- the algorithm comprises two steps S030 and S031 executed in background tasks and a calculation loop of FIGS. RRi intervals.
- the step S030 consists in receiving the discrete values of the digitized signal S1 or S2 and the step S031 consists in the analysis of this signal for the detection of the peaks R or the like (peaks PPG).
- the calculation loop is initiated after detection, at a step S0302, of a peak Ri (Ti),
- the processor stores the peak Ri (Ti) during a step S0306, and then determines during a step S0307 whether the interval RR is greater than a threshold Tmax. If not, the processor supplies the program PG2 with the interval RRi during a step S0308.
- the RRi interval is accompanied by the flag IFR interrupt, which may be in the low or high state depending on the previously executed steps.
- the processor forces the interrupt flag IFR in the low state, then carries out an optional step S0310 of adjusting or "resetting" the thresholds Tmin, Tmax of admissibility of the intervals RRi.
- This step consists of redefining the thresholds Tmin, Tmax as a function of the increase or decrease of the subject's heart rate related to its activity, and involves detection of slow variations of the interval RRi.
- step S0303 When it appears in step S0303 that no peak Ri has been memorized, the processor stores the current peak Ri (Ti) during a step S0312 then goes to step S0311 to increment the index of loop before returning to step S0302.
- step S0305 When it appears in step S0305 that the interval RRi is less than Tmin, the current peak Ri is considered to be aberrant and the processor returns directly to step S0301 to wait for a new peak, without storing the current peak.
- step S0307 When it appears in step S0307 that the interval RRi is greater than Tmax, the processor considers that one or more preceding peaks have not been detected due to an interruption in the reception of the signal S1, S2 or non-peak detection.
- the current peak Ri is considered to be the first peak received after the presumed interruption and the processor goes to a step S0314 where it puts the interrupt flag IFR high and then erases the previous peak Ri-1 (T 1). l) during a step S0315.
- the processor then proceeds to step S0311 to increment the loop variable and returns to step S0302 to wait for a new peak to occur.
- the programs PG1, PG11, or PG12 provide RRi intervals devoid of outliers and accompanied by the IFR interrupt flag enabling the program PG2 to know, when this flag is in the high state, that the corresponding interval RRi is the first RR interval detected after a presumed interruption in the reception of the R peaks.
- FIG. 19 shows an example of an algorithm executed by the processor P3 during the step S05, under the control of the program PG2.
- the formation loop of a time series Sj comprises a step S0503 during which the processor checks whether the IFR interrupt flag associated with the interval RRi received is in the high state. If not, the processor adds the interval RRi to the series Sj during a step S0504, then goes to a step S0505 where it determines whether the cumulative duration of the intervals RRi of the series is greater than or equal to a threshold Te corresponding to the minimum duration of the time series previously mentioned. If not, the processor returns to step S0502 to wait for a new interval RRi.
- the processor goes to a step S0506 where it provides the series Sj to the characterization program PG3 with the IFS interrupt flag in the low or high state according to the previously executed steps.
- a sliding window of time series formation is thus defined, each time series comprising RRi intervals present in the previous time series.
- the processor then forces down the IFS interrupt flag in a step S0509, then returns to step S0502 to wait for a new interval RRi.
- the new time series formed from step S0511 is accompanied by the flag IFS in the high state indicating that the time series Sj is formed after a presumed interruption in the reception of signal S1, S2 or a non-signal. peak detection.
- This series will be supplied to the program PG3 at step S0506 after having received a number of intervals RRi sufficient for the time Te to be reached, if no other interruption intervenes in the meantime.
- the processor determines during a step S112 whether the series Sj is attached to the class C2, namely whether it has a cardiac rhythm disorder.
- step S110 the processor returns to step S110 to reset the count variable d, then goes to step S111 to wait for the classification of the next time series Sj.
- step S112 the series Sj is attached to the class C2
- the processor returns to step S111 to wait for the classification of the next time series Sj. If the threshold D is reached, the processor goes to a step S116 where it indicates to the PAP application program that a rhythm disorder has been detected.
- the threshold D is determined so that the duration of a global observation window encompassing D successive time series, which is less than the sum of the respective durations of the time series because they are generated according to a sliding time window, is sufficiently short, depending on the degree of urgency of the management of the detected rhythm disorder, and long enough for the rhythm disorder to be medically relevant.
- D is 20
- the duration of the time series is of the order of 10 seconds and the sliding window is regenerated with each heart beat.
- a count of a time corresponding to the desired duration of the observation window is provided instead of counting the number of successive series.
- the processor determines whether the classification received consists in an attachment of the time series Sj to the class C 1 of the normal subjects. If the response is positive, the processor returns to step S110, otherwise goes to step S113.
- the device DV3 is initially placed in the "continuous standby" operating mode in which the processor has activated the CH1 channel and has selected it by means of the multiplexer MUX, and the application program PAP switches it into the operating mode "alert” when the decision program PG5 indicates that a rhythm disorder has been detected in the signal S1.
- Figure 21 shows, purely illustrative and not limiting, an example configuration of the DV3 device in the "alert” mode. This configuration comprises an initial step S 120 during which the processor P3: storing in the data memory M32 the previous signal S1 causing the switchover in the "alert” mode, as well as the corresponding time series Sj (Sl) and their classification by the classifier tool PG4,
- the channel CH1 if the channel CH1 is active, stores in the memory M32 the signal S1 received, the corresponding time series Sj (Sl) and their classification by the classifier tool PG4, stores in the memory M32 the signal S2, the corresponding time series Sj (S2) and their classification by the classifier tool PG4.
- the processor waits for a confirmation of a detection, in the signal S2, of the rhythm disorder that caused the switchover to the "alert” mode. It checks during a step S 122 that a time Ta since the switchover in the "alert" mode has not reached a threshold Tmax. If the threshold Tmax is reached without a disturbance of the rhythm has been found in the signal S2, or without the signal S2 has been received (if the user has not responded to the request that him has been addressed to touch the electrode E2), the processor returns to the operating mode "continuous standby", to possibly reboot a few moments later in the "alert” mode if the disorder of the rhythm is again detected in the signal S 1.
- the processor goes to a step S 122 during which it attempts to connect to an SRV server and / or or at a workstation WS shown in Fig. 13, via the wireless communication interface CI3 and an NTW computer or telephone network. If the connection is established, the processor transmits an alert to the remote device and then forwards archived data to it. The user can be informed of the success of the data transfer, for example via an information display.
- the step of connecting to an SRV server and / or to a WS workstation is initiated as soon as the switchover to the "alert" mode, and the aforementioned data are transferred to the remote device without waiting for the confirmation provided for in FIG. Step S 121.
- the device DV3 can then return to the operating mode "continuous standby” or continue to manage the mode of operation "alert” in any way conceivable by those skilled in the art, for example taking into account the number of times where the rhythm disorder has been detected, the behavior of the user facing requests for acquisition of the electrocardiographic signal, etc.
- the user can be offered the possibility to ask the DV3 device to leave the "alert” mode until further notice, if a contact has already been made with the medical profession, or to switch to a mode of operation " silent alert "where the device DV3, while remaining connected to the remote device and / or while continuing to record data from the signal S1, no longer solicits the user to capture the electrocardiographic signal.
- the signal S2 can be captured and stored or transferred for the duration of the "silent alert" mode.
- the user may also be offered the possibility of initiating a cardiac recording himself even if the device has not detected a rhythm disorder by the analysis of the PPG signal.
- the DV1, DV2 and DV3 devices just described are susceptible to various variants, embodiments and applications.
- the general functionalities of the device in particular the prediction of a "continuous sleep" mode of operation where the photoplethysmographic signal is used for heart rate monitoring, and an "alert" mode of operation in which the electrocardiographic signal is captured with or without the user's contribution, are independent of the process implemented to detect a rhythm disorder in each of these signals.
- Ref. 1 M. G. Tsipouras, D. I. Fotiadis, and D. Sideris, "An Arrhythmia Classification System Based on the RR-Interval Signal," Artificial Intelligence in Medicine, vol. 33, pp. 237-250, 2005.
- Ref. 2 "Automatic Detection of Atrial Fibrillation Using RR Interval Signal” Xiuhua Ruan, Liu Changchun, Chengyu Liu, Xinpei Wang, Li Peng, School of Science Control and Engineering, Shandong University, Jinan, Shandong Province, PR China, 250061, 2011, 4th International Conference on Biomedical Engineering and Informatics (BMEI).
- Sj 3 absolute value (
- Sj 4 rate of change (ACi) of the rate of change (Ai) of the RR interval (pulse rate):
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Artificial Intelligence (AREA)
- Fuzzy Systems (AREA)
- Evolutionary Computation (AREA)
- Mathematical Physics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1656215A FR3053237A1 (fr) | 2016-06-30 | 2016-06-30 | Dispositif de detection d'au moins un trouble du rythme cardiaque |
PCT/FR2017/051753 WO2018002541A1 (fr) | 2016-06-30 | 2017-06-29 | Dispositif de détection d'au moins un trouble du rythme cardiaque |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3478168A1 true EP3478168A1 (fr) | 2019-05-08 |
Family
ID=56855701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17740452.2A Pending EP3478168A1 (fr) | 2016-06-30 | 2017-06-29 | Dispositif de détection d'au moins un trouble du rythme cardiaque |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3478168A1 (fr) |
FR (1) | FR3053237A1 (fr) |
WO (1) | WO2018002541A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102073184B1 (ko) * | 2017-09-29 | 2020-02-04 | 한국과학기술원 | 혈압 정보 측정 방법 및 그 장치 |
CN113164072B (zh) * | 2019-02-01 | 2022-12-30 | 深圳市大耳马科技有限公司 | 一种心律失常事件的监测方法和设备 |
CN110192853A (zh) * | 2019-04-30 | 2019-09-03 | 杭州电子科技大学 | 一种基于心电熵值图的心电异常评估方法 |
EP3865060B1 (fr) | 2020-02-13 | 2022-11-30 | Qompium | Procédé mis en uvre par ordinateur pour générer un signal de photopléthysmographie annoté (ppg) |
EP3865059B1 (fr) * | 2020-02-13 | 2022-11-30 | Qompium | Procédé mis en uvre par ordinateur pour la synchronisation d'un signal de photopléthysmographie (ppg) à l'aide d'un signal d'électrocardiogramme (ecg) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7194300B2 (en) | 2004-01-21 | 2007-03-20 | Cardionet, Inc. | Cardiac monitoring |
US7578793B2 (en) * | 2004-11-22 | 2009-08-25 | Widemed Ltd. | Sleep staging based on cardio-respiratory signals |
DE102005013429A1 (de) * | 2005-03-21 | 2006-09-28 | Flore, Ingo, Dr. | Mobiles Diagnosegerät |
US8155735B2 (en) | 2006-09-19 | 2012-04-10 | The Cleveland Clinic Foundation | Prediction and prevention of postoperative atrial fibrillation in cardiac surgery patients |
US8128569B1 (en) * | 2007-12-06 | 2012-03-06 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Method and system for detection of respiratory variation in plethysmographic oximetry |
US8019407B2 (en) | 2008-10-24 | 2011-09-13 | Biotronik Crm Patent Ag | Heart monitoring device and method |
US9420958B2 (en) * | 2013-03-15 | 2016-08-23 | Honda Motor Co., Ltd. | System and method for determining changes in a body state |
EP3052007A1 (fr) * | 2013-10-01 | 2016-08-10 | Koninklijke Philips N.V. | Dispositif, procédé et système pour traiter un signal physiologique |
-
2016
- 2016-06-30 FR FR1656215A patent/FR3053237A1/fr active Pending
-
2017
- 2017-06-29 WO PCT/FR2017/051753 patent/WO2018002541A1/fr unknown
- 2017-06-29 EP EP17740452.2A patent/EP3478168A1/fr active Pending
Also Published As
Publication number | Publication date |
---|---|
FR3053237A1 (fr) | 2018-01-05 |
WO2018002541A1 (fr) | 2018-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3478169A1 (fr) | Procédé de détection d'au moins un trouble du rythme cardiaque | |
WO2018002541A1 (fr) | Dispositif de détection d'au moins un trouble du rythme cardiaque | |
EP3331436A1 (fr) | Procédés et systèmes de stimulation acoustique des ondes cérébrales | |
WO2017085403A1 (fr) | Procede et systeme d'acquisition et d'analyse de donnees physiologiques | |
EP3110321A1 (fr) | Procede, dispositif, systeme et programme informatique de filtrage d'une serie rr obtenue a partir d'un signal cardiaque avec controle automatique de la qualite de la serie rr | |
EP2052680A1 (fr) | Dispositif électrocardiologique d'aide au diagnostic, notamment pour le diagnostic du syndrome de Brugada et de l'ERS | |
EP0597032B1 (fr) | Dispositif de reveil biologique programmable en fonction des phases du sommeil | |
Tsai et al. | Diabetes care in motion: Blood glucose estimation using wearable devices | |
EP3958738A1 (fr) | Procede et systeme de determination d'une valeur de parametre biomecanique avance de demarche | |
WO2017098185A1 (fr) | Procede et systeme de recuperation de donnees de fonctionnement d'un dispositif de mesure des ondes cerebrales | |
WO2003101291A1 (fr) | Traitement frequentiel d'une serie rr dans un signal cardiaque analogique | |
EP3678541A1 (fr) | Systeme d'evaluation de la maturation d'un bebe premature | |
EP0681447A1 (fr) | Dispositif de determination d'informations physiologiques, et utilisation correspondante | |
EP4031005B1 (fr) | Système de détermination d'une émotion d'un utilisateur | |
EP1366428A2 (fr) | Procede et dispositif de filtrage d'une serie rr issue d'un signal cardiaque, et plus particulierement d'un signal ecg | |
WO2017021661A1 (fr) | Procédé et système de stimulation acoustique des ondes cérébrales d'une personne | |
EP4027874B1 (fr) | Procédé de détermination du taux respiratoire | |
EP2684515A1 (fr) | Dispositif médical actif comprenant des moyens de suivi de l'état d'un patient souffrant d'un risque d'insuffisance cardiaque | |
WO2021259958A1 (fr) | Procede de determination de la pression arterielle a partir d'un signal ppg et dispositif correspondant | |
WO2023217730A1 (fr) | Procédé de surveillance du sommeil d'un utilisateur, dispositif de surveillance et programme d'ordinateur correspondants | |
Sopic | Monitoring of Cardiovascular and Neurological Diseases Using Wearable Devices | |
FR3113369A1 (fr) | Procede et systeme de detection de la somnolence d’un individu | |
EP4196008A1 (fr) | Procede et systeme de detection de la somnolence d'un individu | |
FR3113368A1 (fr) | Procede et systeme de detection de la somnolence d’un individu | |
FR3113370A1 (fr) | Procede et systeme de detection de la somnolence d’un individu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20181220 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BOUCHAKOUR, RACHID Inventor name: DELLIAUX, STEPHANE Inventor name: RAHAJANDRAIBE, WENCESLAS Inventor name: CHARAI, AHMED Inventor name: DEHARO, JEAN CLAUDE Inventor name: OULADSINE, MUSTAPHA |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20220330 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61B0005045200 Ipc: A61B0005024000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G16H 50/00 20180101ALI20240229BHEP Ipc: A61B 5/349 20210101ALI20240229BHEP Ipc: A61B 5/024 20060101AFI20240229BHEP |
|
INTG | Intention to grant announced |
Effective date: 20240315 |